Inhibition of the PLP-dependent enzyme serine palmitoyltransferase by cycloserine: evidence for a novel decarboxylative mechanism of inactivation.
Cycloserine (CS, 4-amino-3-isoxazolidone) is a cyclic amino acid mimic that is known to inhibit many essential pyridoxal 5'-phosphate (PLP)-dependent enzymes. Two CS enantiomers are known; D-cycloserine (DCS, also known as Seromycin) is a natural product that is used to treat resistant Mycobacterium tuberculosis infections as well as neurological disorders since it is a potent NMDA receptor agonist, and L-cycloserine (LCS) is a synthetic enantiomer whose usefulness as a drug has been hampered by its inherent toxicity arising through inhibition of sphingolipid metabolism. Previous studies on various PLP-dependent enzymes revealed a common mechanism of inhibition by both enantiomers of CS; the PLP cofactor is disabled by forming a stable 3-hydroxyisoxazole/pyridoxamine 5'-phosphate (PMP) adduct at the active site where the cycloserine ring remains intact. Here we describe a novel mechanism of CS inactivation of the PLP-dependent enzyme serine palmitoyltransferase (SPT) from Sphingomonas paucimobilis. SPT catalyses the condensation of l-serine and palmitoyl-CoA, the first step in the de novo sphingolipid biosynthetic pathway. We have used a range of kinetic, spectroscopic and structural techniques to postulate that both LCS and DCS inactivate SPT by transamination to form a free pyridoxamine 5'-phosphate (PMP) and beta-aminooxyacetaldehyde that remain bound at the active site. We suggest this occurs by ring opening of the cycloserine ring followed by decarboxylation. Enzyme kinetics show that inhibition is reversed by incubation with excess PLP and that LCS is a more effective SPT inhibitor than DCS. UV-visible spectroscopic data, combined with site-directed mutagenesis, suggest that a mobile Arg(378) residue is involved in cycloserine inactivation of SPT.
Lowther
Jonathan
J
EaStChem, School of Chemistry, The University of Edinburgh, West Mains Road, Edinburgh, EH9 3JJ, Scotland, UK.
Yard
Beverley A
BA
Johnson
Kenneth A
KA
Carter
Lester G
LG
Bhat
Venugopal T
VT
Raman
Marine C C
MC
Clarke
David J
DJ
Ramakers
Britta
B
McMahon
Stephen A
SA
Naismith
James H
JH
Campopiano
Dominic J
DJ
D002853:Chromatography, Liquid; D003523:Cycloserine / Q000737:chemistry / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D013058:Mass Spectrometry; D015394:Molecular Structure; D017433:Protein Structure, Secondary; D051102:Serine C-Palmitoyltransferase / Q000037:antagonists & inhibitors* / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D020578:Sphingomonas / Q000201:enzymology
D004791:Enzyme Inhibitors; D003523:Cycloserine; D051102:Serine C-Palmitoyltransferase
J Org Chem. 1971 Sep 10;36(18):2631-4
5130583
Biochemistry. 1964 Apr;3:471-80
14188160
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
15299926
Acta Crystallogr D Biol Crystallogr. 2004 Aug;60(Pt 8):1355-63
15272157
Biochem Pharmacol. 1975 Jun 15;24(11-12):1153-60
1137602
Protein Sci. 2008 Jun;17(6):1066-76
18434499
Cancer Res. 2009 Dec 15;69(24):9457-64
19934323
Biochemistry. 2003 May 20;42(19):5775-83
12741835
J Biochem. 2009 Oct;146(4):549-62
19564159
J Mol Biol. 2007 Jul 27;370(5):870-86
17559874
Biochemistry. 2008 Jul 22;47(29):7734-43
18570438
J Neurochem. 1984 Feb;42(2):577-81
6693888
Biochem Pharmacol. 2000 May 15;59(10):1211-6
10736421
Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):439-50
16552146
Biochemistry. 2004 Feb 3;43(4):1082-92
14744154
J Mol Biol. 2009 Sep 25;392(3):763-73
19631226
J Biol Chem. 1981 May 10;256(9):4263-8
7217082
Structure. 2002 Nov;10(11):1569-80
12429098
J Biol Chem. 1962 Oct;237:3245-9
14033211
J Biol Chem. 2004 Oct 29;279(44):46153-61
15302886
J Biol Chem. 2008 Mar 21;283(12):7542-53
18167344
J Lipid Res. 1965 Oct;6(4):537-44
5865382
Biochim Biophys Acta. 2003 Jun 10;1632(1-3):16-30
12782147
Biochemistry. 2000 Jan 25;39(3):516-28
10642176
Nat Chem Biol. 2007 Sep;3(9):565-9
17676039
Antimicrob Agents Chemother. 1984 Aug;26(2):211-3
6486763
J Biol Chem. 2008 Jun 27;283(26):18113-23
18411263
Nat Rev Mol Cell Biol. 2008 Feb;9(2):139-50
18216770
J Lipid Res. 1985 Apr;26(4):473-7
4009064
Biochim Biophys Acta. 2009 Jul;1794(7):1030-40
19328247
Antibiot Chemother (Northfield). 1955 Apr;5(4):204-5
24543467
Proc Natl Acad Sci U S A. 2009 May 19;106(20):8186-91
19416851
Arch Microbiol. 1982 May;131(3):208-11
7049104
Nat Chem Biol. 2009 Dec;5(12):891-5
19838203
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
J Biol Chem. 2009 Jun 19;284(25):17328-17339
19376777
FEBS Lett. 2000 May 26;474(1):63-5
10828452
Antibiot Chemother (Northfield). 1955 Apr;5(4):183-90
24543464
J Lipid Res. 2008 Aug;49(8):1621-39
18499644
Bioorg Med Chem Lett. 2007 Mar 15;17(6):1651-4
17267220
J Antimicrob Chemother. 2004 Sep;54(3):593-602
15282233
Biochemistry. 2001 May 1;40(17):5151-60
11318637
Annu Rev Biochem. 2004;73:383-415
15189147
Pharmacol Res. 2008 Jul;58(1):45-51
18611440
FEBS J. 2008 Dec;275(23):5767-73
19021754
J Bioenerg Biomembr. 1995 Apr;27(2):151-9
7592562
J Biol Chem. 2002 Nov 22;277(47):44660-9
12191993
J Mol Biol. 1999 Nov 19;294(1):193-200
10556038
Neuropharmacology. 2001 Aug;41(2):151-8
11489451
EMBO Rep. 2004 Aug;5(8):777-82
15289826
Biochemistry. 2005 Apr 12;44(14):5317-27
15807525
Nature. 1997 Jun 5;387(6633):569-72
9177342
J Mol Biol. 1998 Nov 27;284(2):401-19
9813126